Lexicon Pharmaceuticals Share Price Today
(NASDAQ: LXRX)

Name: Lexicon Pharmaceuticals Share Price Today (NASDAQ: LXRX) - Lexicon Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Lexicon Pharmaceuticals share price is $0.73 & ₹61.82 as on 1 May 2025, 2.30 'hrs' IST

$0.73

▲

0.06

(9.27%)

Market is closed - opens 7 PM, 01 May 2025

View live Lexicon Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Lexicon Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Lexicon Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Lexicon Pharmaceuticals share price movements

Today's Low: $0.65
Today's High: $0.74
$0.73
10.96%
Downside
Day's Volatility :11.8%
Upside
0.95%
52 Weeks Low: $0.28
52 Weeks High: $2.45
$0.73
61.15%
Downside
52 Weeks Volatility :88.42%
Upside
70.2%

Lexicon Pharmaceuticals (LXRX) Returns

Period	Lexicon Pharmaceuticals, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-17.96%	-5.2%	0.0%
6 Months	-44.9%	-5.7%	0.0%
1 Year	-59.26%	-0.9%	0.0%
3 Years	-65.17%	6.9%	-5.1%

Lexicon Pharmaceuticals (LXRX) Key Statistics

in dollars & INR

Previous Close	$0.6688
Open	$0.6709
Today's High	$0.737
Today's Low	$0.65
Market Capitalization	$249.9M
Today's Volume	$3.4M
52 Week High	$2.45
52 Week Low	$0.2836
Revenue TTM	$31.1M
EBITDA	$-184.3M
Earnings Per Share (EPS)	$-0.63
Profit Margin	0.0%
Quarterly Earnings Growth YOY	-0.63%
Return On Equity TTM	-167.66%

How to invest in Lexicon Pharmaceuticals Stock (LXRX) from India?

It is very easy for Indian residents to invest directly in Lexicon Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lexicon Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lexicon Pharmaceuticals or LXRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lexicon Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lexicon Pharmaceuticals shares which would translate to 1.160 fractional shares of Lexicon Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lexicon Pharmaceuticals, in just a few clicks!

Returns in Lexicon Pharmaceuticals (LXRX) for Indian investors in Rupees

The Lexicon Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Lexicon Pharmaceuticals investment value today

Current value as on today

₹45,710

Returns

₹54,290

(-54.29%)

Returns from Lexicon Pharmaceuticals Stock

₹55,758 (-55.76%)

Dollar Returns

₹1,467 (+1.47%)

Indian investors sentiment towards Lexicon Pharmaceuticals (LXRX)

-65.36%

Period: Mar 31, 2025 to Apr 30, 2025. Change in 30 Days versus previous period

Investment in Lexicon Pharmaceuticals Shares from India has dropped by -65.36% over the past 30 days, indicating reduced transactional activity.

15%

Period: Mar 31, 2025 to Apr 30, 2025. Change in 30 Days versus previous period

Search interest for Lexicon Pharmaceuticals Stock from India on INDmoney has increased by 15% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Lexicon Pharmaceuticals

Artal Group S A
37.67%
FMR Inc
14.38%
Siren, L.L.C.
10.77%
BlackRock Inc
2.86%
Vanguard Group Inc
2.73%
Point72 Asset Management, L.P.
2.49%

Analyst Recommendation on Lexicon Pharmaceuticals

Rating

Trend

Buy

72%Buy

27%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Lexicon Pharmaceuticals(by analysts ranked 0 to 5 stars)

Analyst Forecast on Lexicon Pharmaceuticals Stock (LXRX)

What analysts predicted

Upside of 256.16%

Target:

$2.60

Current:

$0.73

Insights on Lexicon Pharmaceuticals Stock (Ticker Symbol: LXRX)

Price Movement
In the last 1 month, LXRX stock has moved up by 44.8%
Increasing Revenue
Revenue is up for the last 6 quarters, 162.0K → 26.55M (in $), with an average increase of 49.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -64.81M → -33.76M (in $), with an average increase of 91.9% per quarter
LXRX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 71.6% return, outperforming this stock by 130.9%
LXRX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 92.8% return, outperforming this stock by 155.7%
Price to Sales
ForLXRX every $1 of sales, investors are willing to pay $7.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Lexicon Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Lexicon Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Lexicon Pharmaceuticals (LXRX) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Lexicon Pharmaceuticals, Inc.	45.88%	-44.9%	-59.26%	-65.17%	-64.43%
Biontech Se	14.33%	-7.95%	15.74%	-28.71%	127.41%
Regeneron Pharmaceuticals, Inc.	-7.79%	-32.13%	-37.03%	-12.75%	5.0%
Vertex Pharmaceuticals Incorporated	3.75%	5.66%	25.06%	91.98%	90.0%
Alnylam Pharmaceuticals, Inc.	0.61%	-3.48%	71.59%	85.05%	88.33%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Lexicon Pharmaceuticals, Inc.	NA	NA	-0.14	-0.43	-1.68	-0.44	NA	0.4
Biontech Se	160.8	NA	0.04	-5.11	-0.03	-0.04	NA	80.89
Regeneron Pharmaceuticals, Inc.	15.94	15.94	0.96	39.38	0.16	0.07	0.01	273.57
Vertex Pharmaceuticals Incorporated	32.84	NA	1.35	17.95	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.72	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Lexicon Pharmaceuticals, Inc.	Buy	$249.9M	-64.43%	NA	0.0%
Biontech Se	Buy	$29.5B	127.41%	160.8	-24.18%
Regeneron Pharmaceuticals, Inc.	Buy	$66.5B	5.0%	15.94	31.07%
Vertex Pharmaceuticals Incorporated	Buy	$127.6B	90.0%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.0B	88.33%	NA	-12.37%

About Lexicon Pharmaceuticals

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company offers Sotagliflozin, an orally-delivered small molecule drug to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure or type 2 diabetes mellitus, chronic kidney disease or CKD, and other cardiovascular risk factors. Its orally-delivered small molecule drug candidates under development include sotagliflozin for the treatment of hypertrophic cardiomyopathy or HCM and type 1 diabetes that is in Phase 3 clinical trial; LX9211, which has completed Phase II clinical trials for the treatment of neuropathic pain; and LX9851 for the treatment of obesity and associated cardiometabolic disorders, as well as for weight management. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Organization	Lexicon Pharmaceuticals
Employees	103
CEO	Dr. Michael S. Exton Ph.D.
Industry	Health Technology

Management People of Lexicon Pharmaceuticals

Name	Title
Dr. Michael S. Exton Ph.D.	CEO & Director
Ms. Kristen L. Alexander	Vice President of Finance & Accounting
Mr. Brian T. Crum	Senior VP, General Counsel & Secretary
Dr. Alan J. Main Ph.D.	Executive Vice President of Innovation & Chemical Sciences
Dr. Craig B. Granowitz M.D., Ph.D.	Senior VP & Chief Medical Officer
Mr. Scott M. Coiante	Senior VP & CFO
Ms. Lisa M. DeFrancesco	Senior Vice President of Investor Relations & Corporate Communications
Mr. Dixon Terry	Vice President of Compliance
Ms. Carrie Siragusa	Vice President of Marketing
Ms. Desiree Gendron	Vice President of Sales & Training

Important FAQs about investing in LXRX Stock from India :

What is Lexicon Pharmaceuticals share price today?

Lexicon Pharmaceuticals share price today stands at $0.73, Open: $0.67 ; Previous Close: $0.67 ; High: $0.74 ; Low: $0.65 ; 52 Week High: $2.45 ; 52 Week Low: $0.28.

The stock opens at $0.67, after a previous close of $0.67. The stock reached a daily high of $0.74 and a low of $0.65, with a 52-week high of $2.45 and a 52-week low of $0.28.

Can Indians buy Lexicon Pharmaceuticals shares?

Yes, Indians can invest in the Lexicon Pharmaceuticals (LXRX) from India.

With INDmoney, you can buy Lexicon Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Lexicon Pharmaceuticals at zero transaction cost.

How can I buy Lexicon Pharmaceuticals shares from India?

It is very easy to buy Lexicon Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lexicon Pharmaceuticals (LXRX) be purchased?

Yes, you can buy fractional shares of Lexicon Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Lexicon Pharmaceuticals stocks?

To start investing in Lexicon Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.